Disruption Is Permanent. Is the Industry Ready?

Medical Device Supply Chains

This article challenges a core assumption in MedTech operations: that resilience can be built through prediction. Instead, it presents a more urgent and practical insight, that disruption is now structural, and competitive advantage lies in how quickly organisations recover when failure occurs. It surfaces the often-hidden fragilities embedded deep within multi-tier supply networks, where single points of failure, regulatory constraints, and scarce inputs can trigger disproportionate impact on both performance and patient care. 

By reframing resilience as a capability rooted in speed, prioritisation, and pre-defined decision-making, the piece offers MedTech leaders a sharper lens on where their networks are most exposed and how to act decisively when it matters most.